Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.

about

S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.

P2860

Q36735918-3AE042D9-53B9-4647-9B2F-B3D5521AA913 Q39178864-55340DF7-AFC1-4FB5-BB53-92995FAFB84D

P2860

Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.

Item

http://www.wikidata.org/entity/Q38287712

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.

@en

type

Item

label

Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.

@en

prefLabel

Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.

@en

P1476

Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.

@en

P2093

Francesco d'Amore

http://www.w3.org/2001/XMLSchema#string

Maja Ludvigsen

http://www.w3.org/2001/XMLSchema#string

P2860

Finishing the euchromatic sequence of the human genome

Distinguishing protein-coding and noncoding genes in the human genome

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Accessories to the crime: functions of cells recruited to the tumor microenvironment

Two-dimensional molecular profiling of mantle cell lymphoma.

Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma.

Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides

Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications.

Protein biomarker identification in the CSF of patients with CNS lymphoma.

Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning.

P304

72-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRCA.201400145

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bent Honoré

Stephen Hamilton-Dutoit

P577

2015-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25504580

http://www.w3.org/2001/XMLSchema#string

Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.

about

P2860

P2860

Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698